Loading provider…
Loading provider…
Cardiovascular Disease Physician in Pomona, CA
NPI: 1346217551Primary Employer
Indus Healthcare, Inc.
indushealthcare.org
HQ Phone
Get MD Yogesh's Phone Numberphone_androidMobile
Get MD Yogesh's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
NY State Medical License
1979
CA State Medical License
1980 - 2026
OH State Medical License
1993 - 1998
MD State Medical License
1979 - 1979
University of California (Irvine)
Fellowship • Cardiovascular Disease
1980 - 1982
NYU Grossman School of Medicine/Brooklyn Campus
Residency • Internal Medicine
1978 - 1980
AC Logan Memorial Hospital
Internship • Internal Medicine
1977 - 1978
S.N. Medical College Agra
Medical School
Until 1970
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 93306Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | 291 | 296 |
| 2 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 258 | 2,025 |
| 3 | 99214Established patient office or other outpatient visit, 30-39 minutes | 257 | 618 |
| 4 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 231 | 260 |
| 5 | 93010Routine electrocardiogram (EKG) using at least 12 leads with interpretation and report | 163 | 263 |
Identification of Septal Ischemia During Exercise By Q-Wave Analysis: Correlation With Coronary Angiography
Authors: Michael Famularo
Lead Sponsor: Evofem Inc.
Collaborators: Parexel
Intervention / Treatment: DRUG: AMPHORA
Lead Sponsor: Suven Life Sciences Limited
Intervention / Treatment: DRUG: Placebo, DRUG: SUVN-G3031
Lead Sponsor: Sol-Gel Technologies, Ltd.
Collaborators: Accelovance
Intervention / Treatment: DRUG: S6G5T-3, DRUG: S6G5T-1, DRUG: S6G5T-5, DRUG: S6G5T-6, DRUG: S6G5T-7, DRUG: S6G5T-8